464 related articles for article (PubMed ID: 30066920)
1. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
[TBL] [Abstract][Full Text] [Related]
3. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
4. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
5. A novel microRNA signature predicts survival in stomach adenocarcinoma.
Ding B; Gao X; Li H; Liu L; Hao X
Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
[TBL] [Abstract][Full Text] [Related]
6. A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
Xu M; Kuang Y; Wang M; Han X; Yang Q
Neoplasma; 2017; 64(1):56-64. PubMed ID: 27881005
[TBL] [Abstract][Full Text] [Related]
7. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
Ruan GT; Wang S; Zhu LC; Liao XW; Wang XK; Liao C; Yan L; Xie HL; Gong YZ; Gan JL; Gao F
Aging (Albany NY); 2021 Apr; 13(9):12565-12586. PubMed ID: 33909599
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
Wang JY; Wang CL; Wang XM; Liu FJ
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2114-2129. PubMed ID: 28537673
[TBL] [Abstract][Full Text] [Related]
9. Identification prognosis-associated immune genes in colon adenocarcinoma.
Miao Y; Wang J; Ma X; Yang Y; Mi D
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
[TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic miRNA biomarkers for predicting overall survival of colon adenocarcinoma and bioinformatics analysis: A study based on The Cancer Genome Atlas database.
Chen F; Li Z; Zhou H
J Cell Biochem; 2019 Jun; 120(6):9839-9849. PubMed ID: 30536901
[TBL] [Abstract][Full Text] [Related]
11. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
[TBL] [Abstract][Full Text] [Related]
12. MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method.
Li Z; Jiang L; Zhao R; Huang J; Yang W; Wen Z; Zhang B; Du G
Medicine (Baltimore); 2021 May; 100(21):e26068. PubMed ID: 34032736
[TBL] [Abstract][Full Text] [Related]
13. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction.
Wang Z; Niu D
Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070
[TBL] [Abstract][Full Text] [Related]
14. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
15. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P
Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267
[TBL] [Abstract][Full Text] [Related]
16. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
Shi XH; Li X; Zhang H; He RZ; Zhao Y; Zhou M; Pan ST; Zhao CL; Feng YC; Wang M; Guo XJ; Qin RY
Sci Rep; 2018 May; 8(1):7638. PubMed ID: 29769534
[TBL] [Abstract][Full Text] [Related]
17. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
Wang XJ; Zeng B; Lin S; Chen M; Chi P
Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
[TBL] [Abstract][Full Text] [Related]
18. Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma.
Poursheikhani A; Abbaszadegan MR; Nokhandani N; Kerachian MA
BMC Med Genomics; 2020 Jul; 13(1):108. PubMed ID: 32727450
[TBL] [Abstract][Full Text] [Related]
19. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X
J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481
[TBL] [Abstract][Full Text] [Related]
20. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
